Statistics
Publications
16
Citations
1.5K
H-Index
14
Active since
1999
Daniel D. Kaplan is an author at NGM Biopharmaceuticals (United States) specializing in life sciences, cell biology, and cell signaling.
Publications per year
1999–2024
16
16
LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor
Xuecai Ge, Hong Yang, Maria A. Bednarek et al. · Cell Metabolism · 2017 · 364 citations · Full text
β-Catenin is a Nek2 substrate involved in centrosome separation
Shirin Bahmanyar, Daniel D. Kaplan, Jennifer G. DeLuca et al. · Genes & Development · 2007 · 222 citations · Full text
1–5 of 16